Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Akero Therapeutics
AKRO
$3.48B
| $27.2M | ﹤0.01% |
1,166,245
+62,939
| +6% | +$1.47M |
|
1727
Madison Square Garden
MSGE
$2.1B
| $27.2M | ﹤0.01% |
855,062
+3,809
| +0.4% | +$121K |
|
|
RYZB
1728
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $27M | ﹤0.01% |
434,891
+390,406
| +878% | +$24.3M |
|
1729
Steelcase
SCS
$1.93B
| $26.9M | ﹤0.01% |
1,988,762
+87,285
| +5% | +$1.18M |
|
1730
Malibu Boats
MBUU
$629M
| $26.9M | ﹤0.01% |
490,289
+16,664
| +4% | +$914K |
|
|
PRMW
1731
DELISTED
Primo Water Corporation
PRMW
| $26.9M | ﹤0.01% |
1,785,255
+84,952
| +5% | +$1.28M |
|
1732
Zeta Global
ZETA
$4.84B
| $26.8M | ﹤0.01% |
3,041,961
+169,931
| +6% | +$1.5M |
|
|
SASR
1733
DELISTED
Sandy Spring Bancorp Inc
SASR
| $26.8M | ﹤0.01% |
982,643
+47,357
| +5% | +$1.29M |
|
1734
Sprinklr
CXM
$1.88B
| $26.8M | ﹤0.01% |
2,222,979
+161,515
| +8% | +$1.94M |
|
|
BBBY
1735
Bed Bath & Beyond, Inc.
BBBY
$596M
| $26.7M | ﹤0.01% |
965,112
+6,432
| +0.7% | +$178K |
|
1736
Reynolds Consumer Products
REYN
$4.84B
| $26.7M | ﹤0.01% |
993,687
+32,446
| +3% | +$871K |
|
1737
UFP Technologies
UFPT
$1.54B
| $26.6M | ﹤0.01% |
154,867
+7,562
| +5% | +$1.3M |
|
1738
Compass
COMP
$4.92B
| $26.6M | ﹤0.01% |
7,081,291
+311,801
| +5% | +$1.17M |
|
|
AAT
1739
American Assets Trust
AAT
$1.27B
| $26.6M | ﹤0.01% |
1,181,557
+37,803
| +3% | +$851K |
|
1740
John Wiley & Sons Class A
WLY
$2.19B
| $26.5M | ﹤0.01% |
835,620
-39,280
| -4% | -$1.25M |
|
1741
Ligand Pharmaceuticals
LGND
$3.23B
| $26.5M | ﹤0.01% |
370,815
+18,194
| +5% | +$1.3M |
|
1742
Magnite
MGNI
$3.4B
| $26.4M | ﹤0.01% |
2,830,547
+157,566
| +6% | +$1.47M |
|
1743
Kinross Gold
KGC
$28.4B
| $26.4M | ﹤0.01% |
4,401,012
+156,198
| +4% | +$938K |
|
1744
Seadrill
SDRL
$2.04B
| $26.4M | ﹤0.01% |
558,181
+27,543
| +5% | +$1.3M |
|
1745
Legend Biotech
LEGN
$6.11B
| $26.4M | ﹤0.01% |
440,875
+79,673
| +22% | +$4.77M |
|
1746
Encore Capital Group
ECPG
$1.02B
| $26.3M | ﹤0.01% |
518,809
+23,667
| +5% | +$1.2M |
|
1747
XPEL
XPEL
$960M
| $26.3M | ﹤0.01% |
487,654
+22,810
| +5% | +$1.23M |
|
1748
OneSpaWorld
OSW
$2.24B
| $26.2M | ﹤0.01% |
1,860,348
+101,970
| +6% | +$1.44M |
|
1749
Winmark
WINA
$1.74B
| $26.1M | ﹤0.01% |
62,563
+2,703
| +5% | +$1.13M |
|
|
INBX
1750
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $26.1M | ﹤0.01% |
687,360
+41,201
| +6% | +$1.57M |
|